智通财经APP获悉,第九届特发性肺纤维化(IPF)峰会于2025年8月19日至21日在美国波士顿召开。东阳光药(06887)亮相本次峰会,首席科学家林凯博士在大会主议程中首次公开披露在研抗纤维化创新药伊非尼酮(HEC585)的II期临床试验关键数据,这一重要发布瞬间吸引了在场众多科学家的目光,引发了广泛关注与热烈讨论,成为峰会的一大焦点。众所众知,美国IPF峰会作为全球肺纤维化研究领域最具权威性和...
Source Link智通财经APP获悉,第九届特发性肺纤维化(IPF)峰会于2025年8月19日至21日在美国波士顿召开。东阳光药(06887)亮相本次峰会,首席科学家林凯博士在大会主议程中首次公开披露在研抗纤维化创新药伊非尼酮(HEC585)的II期临床试验关键数据,这一重要发布瞬间吸引了在场众多科学家的目光,引发了广泛关注与热烈讨论,成为峰会的一大焦点。众所众知,美国IPF峰会作为全球肺纤维化研究领域最具权威性和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.